Champix, which launched in the UK in 2006, has previously been linked to heart problems, strokes and blackouts - now experts claim patients taking the anti-smoking pill are more prone to depression, ...
LONDON (MarketWatch) -- Pfizer Inc. said that the U.K. National Institute for Health and Clinical Excellence has recommended its Champix (varenicline) treatment for use on the National Health Service.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback